Data for ST004230   

(Analysis AN007041): Average values per metabolite and experimental factor (Units:normalized peak area)

Metabolite structureAll dataF1F2F3F4F5F6F7
1-O-Palmitoyl-Cer(d18:1/18:0)
- - - - - - -
24-Hydroxycholesterol
- - - - - - -
24-Hydroxycholesterol(d7)
- - - - - - -
3-O-SulfoLacCer(d18:1/18:0)
- - - - - - -
4-beta-Hydroxycholesterol
- - - - - - -
7-keto-Cholesterol
- - - - - - -
CE(16:1)
- - - - - - -
CE(18:1)
- - - - - - -
CE(18:1(d7))
- - - - - - -
CE(18:2)
- - - - - - -
CE(20:4)
- - - - - - -
CE(20:5)
- - - - - - -
CE(22:6)
- - - - - - -
CE HETE
- - - - - - -
CE HODE
- - - - - - -
CE HpODE
- - - - - - -
CE oxoHETE
- - - - - - -
CE oxoODE
- - - - - - -
Cer(d18:0/16:0)
- - - - - - -
Cer(d18:0/18:0)
- - - - - - -
Cer(d18:0/24:0)
- - - - - - -
Cer(d18:0/24:1)
- - - - - - -
Cer(d18:1/16:0)
0.57 0.59 0.11 0.12 0.41 0.28 0.43
Cer(d18:1/16:0(d7))
- - - - - - -
Cer(d18:1/18:0)
0.43 0.48 1.20 1.37 1.04 0.83 1.09
Cer(d18:1/24:0)
0.41 0.51 0.08 0.08 0.34 0.31 0.43
Cer(d18:1/24:1)
0.99 1.22 0.12 0.14 0.61 0.52 0.76
Cholesterol
- - - - - - -
Cholesterol(d7)
- - - - - - -
Cholesteryl hexoside
- - - - - - -
Coenzyme Q10
- - - - - - -
DG(15:0/18:1(d7))
- - - - - - -
DG(16:0_18:1)
0.56 0.58 0.60 0.58 0.60 0.63 0.65
DG(16:0_20:4)
0.21 0.15 0.07 0.08 0.10 0.08 0.13
DG(18:0_18:1)
- - - - - - -
DG(18:0_20:4)
0.13 0.16 0.19 0.31 0.11 0.14 0.31
DG(18:0_22:6)
0.26 0.78 0.28 0.27 0.33 0.75 0.36
DG(18:1/18:1)
1.58 1.67 1.68 1.64 1.76 1.71 1.98
DG(18:1_20:4)
- - - - - - -
GB3(d18:1/16:0)
- - - - - - -
GB3(d18:1/18:0)
- - - - - - -
GB3(d18:1/18:0(d3))
- - - - - - -
GB3(d18:1/24:0)
- - - - - - -
GB3(d18:1/24:1)
- - - - - - -
GlcCer(d18:1/16:0(d3))
- - - - - - -
GlcCer(d18:1(d5)/18:0)
- - - - - - -
Glucosylsphingosine(d5)
- - - - - - -
HexCer(d18:1/12:0)
- - - - - - -
HexCer(d18:1/16:0)
0.06 0.03 - 0.02 0.02 0.01 0.02
HexCer(d18:1/18:0)
0.04 0.05 0.08 0.10 0.06 0.06 0.10
HexCer(d18:1/22:0)
0.10 0.14 0.13 0.13 0.12 0.11 0.20
HexCer(d18:1/24:0)
0.07 0.10 0.09 0.16 0.10 0.07 0.16
HexCer(d18:1/24:1)
0.14 0.19 0.63 0.92 0.26 0.25 0.63
Hexosylsphingosine
- - - - - - -
LacCer(d18:1/16:0)
- - - - - - -
LacCer(d18:1/17:0)
- - - - - - -
LacCer(d18:1/18:0)
- - - - - - -
LacCer(d18:1/24:0)
- - - - - - -
LacCer(d18:1/24:1)
- - - - - - -
Lactosylsphingosine
- - - - - - -
LPC(16:0)
0.03 0.04 0.03 0.04 0.03 0.04 0.04
LPC(16:1)
- - - - - - -
LPC(18:0)
0.14 0.13 0.19 0.15 0.15 0.14 0.16
LPC(18:1)
0.02 0.03 0.03 0.03 0.03 0.03 0.03
LPC(18:1(d7))
- - - - - - -
LPC(20:4)
0.01 0.01 0.00 0.00 0.01 0.01 0.01
LPC(22:6)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
LPC(24:0)
- - - - - - -
LPC(24:1)
- - - - - - -
LPC(26:0)
- - - - - - -
LPC(26:1)
- - - - - - -
lyso-GB3
- - - - - - -
lyso-GB3-d7
- - - - - - -
lyso-GB4
- - - - - - -
MG(16:0)
18.73 17.82 20.21 20.93 16.78 22.40 26.35
MG(16:1)
- - - - - - -
MG(18:0)
98.56 91.17 100.33 102.58 93.15 109.82 113.62
MG(18:1)
1.77 1.67 1.82 1.84 1.64 1.98 2.32
MG(18:1(d7))
- - - - - - -
MG(20:4)
- - - - - - -
N-Oleoylethanolamine
- - - - - - -
N-Palmitoyl-O-phosphocholineserine
- - - - - - -
Palmitoylethanolamine
- - - - - - -
PC(15:0/18:1(d7))
- - - - - - -
PC(16:0/5:0(CHO))
0.01 0.02 0.01 0.01 0.02 0.01 0.02
PC(16:0/9:0(CHO))
0.03 0.06 0.04 0.04 0.05 0.05 0.05
PC(16:0/9:0(COOH))
0.01 0.01 0.01 0.01 0.01 0.01 0.01
PC(18:0/20:4(OH[S]))
- - - - - - -
PC(18:0/20:4(OOH[S]))
- - - - - - -
PC(34:1)
1.42 1.93 1.22 1.69 1.58 1.35 2.05
PC(36:1)
0.13 0.19 0.38 0.51 0.24 0.22 0.38
PC(36:2)
0.26 0.32 0.16 0.20 0.23 0.21 0.34
PC(36:4)
1.61 2.06 0.20 0.26 1.19 0.99 1.60
PC(38:4)
0.28 0.39 0.14 0.19 0.36 0.29 0.40
PC(38:6)
0.12 0.16 0.10 0.14 0.17 0.14 0.18
PC(40:5)
0.01 0.01 0.01 0.01 0.01 0.01 0.01
PC(40:6)
0.03 0.04 0.05 0.07 0.07 0.06 0.07
PC(O-16:0/0:0)
- - - - - - -
PC(O-16:0/2:0)
0.00 0.01 0.00 0.00 0.00 0.00 0.01
PC(O-18:0/2:0)
- - - - - - -
PE(15:0/18:1(d7))
- - - - - - -
PE(18:0/20:4(OH[S]))
- - - - - - -
PE(18:0/20:4(OOH[S]))
- - - - - - -
PE(34:1)
0.83 1.13 1.10 1.32 0.77 0.62 1.16
PE(36:1)
0.57 0.71 1.32 1.83 0.81 0.66 1.10
PE(36:2)
0.55 0.76 1.20 1.81 0.56 0.61 1.23
PE(36:4)
1.47 1.87 0.45 0.54 0.98 0.90 1.34
PE(38:4)
2.44 3.53 2.06 2.99 2.89 2.46 3.47
PE(38:5)
0.70 0.87 0.56 0.77 0.59 0.58 0.89
PE(38:6)
1.13 1.47 0.88 1.42 1.24 0.88 1.42
PE(40:4)
0.38 0.42 0.55 0.66 0.49 0.35 0.50
PE(40:5)
- - - - - - -
PE(40:6)
1.56 2.40 3.24 4.99 3.17 2.69 3.46
PE(40:7)
0.45 0.50 0.30 0.41 0.52 0.45 0.51
Sitosteryl hexoside
- - - - - - -
SM(d18:1/16:0)
0.29 0.38 0.20 0.18 0.24 0.23 0.32
SM(d18:1/18:0)
0.11 0.17 0.29 0.42 0.20 0.17 0.30
SM(d18:1/24:0)
0.05 0.10 0.03 0.03 0.05 0.08 0.12
SM(d18:1/24:1)
0.20 0.30 0.08 0.10 0.14 0.15 0.23
SM(d18:1(d9)/18:1)
- - - - - - -
Sphinganine
- - - - - - -
Sphinganine 1-phosphate
- - - - - - -
Sphingosine
- - - - - - -
Sphingosine 1-phosphate
- - - - - - -
Sphingosine 1-phosphate-d7
- - - - - - -
Sphingosine 1-phosphocholine
- - - - - - -
Sphingosine(d17:1)
- - - - - - -
TG(15:0/18:1(d7)/15:0)
- - - - - - -
TG(18:0_36:2)
0.89 0.96 0.94 0.98 0.98 0.88 1.18
TG(18:1_34:2)
2.81 3.00 3.01 3.10 3.14 2.73 3.65
TG(18:1_34:3)
0.42 0.44 0.46 0.47 0.47 0.42 0.60
TG(20:4_32:1)
- - - - - - -
TG(20:4_34:2)
0.04 0.05 0.05 0.04 0.05 0.04 0.05
TG(20:4_34:3)
- - - - - - -
TG(20:4_36:0)
- - - - - - -
TG(20:4_36:2)
- - - - - - -
TG(20:4_36:3)
- - - - - - -
TG(22:6_36:2)
- - - - - - -
TG(22:6_38:1)
- - - - - - -
TG(22:6_38:2)
- - - - - - -

Factors:

F1condition:high | treatment:ATV 4D9 | Sample source:microglia
F2condition:high | treatment:ATV Iso | Sample source:microglia
F3condition:low | treatment:ATV 4D9 | Sample source:microglia
F4condition:low | treatment:ATV Iso | Sample source:microglia
F5condition:mid | treatment:ATV 4D9 | Sample source:microglia
F6condition:mid | treatment:ATV Iso | Sample source:microglia
F7condition:NA | treatment:NA | Sample source:microglia
  logo